More about
Santen Inc.
Santen has been a leader in ophthalmic innovation for nearly 120 years. Our pioneering vision and open-minded thinking have led to the discovery, development, and introduction of a select series of firsts, including one of the world’s first ophthalmic anti-infectives in the quinolone class, the treatment of first choice for eye infections, and the longest-selling ophthalmic brand in Japan. By leveraging the advantages of both independent innovation and successful collaboration, Santen has advanced the future of ophthalmology with unprecedented insight and energy.
To find out more how Santen is committed to applying unique capabilities in order to contribute to the health and quality of life of patients, their families, and society as a whole please visit Santeninc.com.
Learn More